A multi-peptide blend combining GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg) for research exploring synergistic effects in tissue repair and extracellular matrix signaling. This formulation targets complementary pathways across collagen synthesis, actin regulation, and cellular recovery.
GLOW combines GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg) into a single research formulation. In laboratory settings, it is used to examine how peptide systems associated with copper transport, vascular signaling, extracellular matrix activity, cell migration, and structural pathway regulation may function together within the same experimental model.
GLOW is studied through the combined pathway activity of its three components. GHK-Cu is commonly examined for copper-binding and extracellular matrix-related signaling, TB-500 for actin dynamics and cell-migration biology, and BPC-157 for angiogenic, nitric oxide-related, and growth factor-mediated pathway activity. As a blend, it is commonly used in research involving connective tissue biology, vascular signaling, fibroblast-related models, skin-associated pathway research, and broader structural recovery signaling systems.
GLOW reflects the broader move toward multi-peptide research formulations that combine several well-known pathway targets into one product. Vendor documentation positions it specifically as a blend of GHK-Cu, TB-500, and BPC-157 for coordinated structural and tissue-related research, rather than as a single new standalone compound with its own independent chemical identity.
For research use only. Not for human or veterinary use. Detailed storage guidelines →